- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03325946
The FBRI VTC Neuromotor Research Clinic
The FBRI VTC Neuromotor Research Clinic was established and opened in May of 2013 to provide intensive therapeutic services to individuals with motor impairment secondary to neuromotor disorders. It is direct by Dr. Stephanie DeLuca and based on the principles surrounding ACQUIREc Therapy.
ACQUIREc Therapy is an evidenced-based approach to pediatric constraint-induced movement therapy, which refers to a multi-component form of therapy that is focused on helping children who have asymmetric motor abilities between the two sides of the body. Historically, ACQUIREc Therapy has the unimpaired or less impaired upper extremity constrained (by a cast or a splint) while also receiving active therapy from a specially trained therapist who shapes new skills and functional activities with the child's more impaired upper extremity but who is also a licensed Occupational or Physical Therapist (OT/PT). Therapy dosages are high much higher than tradition OT or PT - often lasting many hours per day, up to 6 hours a day, 5 days a week, for 2-4 weeks.
Investigators have developed further treatments based on the same principles of intensive services combined with behavior shaping for other areas of the body that are also affected by weakness (e.g., the leg and trunk) also, but which usually do not involve constraint. These have been more generally labeled ACQUIRE Therapy.
All forms involve intensive, play-based therapy for children with asymmetric motor impairments of the arms and hands. The primary focus of treatment is to facilitate the acquisition of new motor skills in the child's weaker body parts through high levels of intensive therapy using scientifically-based behavioral guidelines. Therapy is also delivered in naturalistic environments.
ACQUIREc Therapy as a treatment method has been tested in two randomized controlled trials, and a specific manual for its implementation has been developed. Dr. (s) Ramey and DeLuca previously founded a similar clinic, The Pediatric Neuromotor Research Clinic, at the University of Alabama at Birmingham where Dr. DeLuca directed the research clinic for 13 years and oversaw the implementation of the ACQUIREc Therapy treatment protocol in more than 400 cases.
This research will involve analyzing and interpreting the clinical data of children going through clinical procedures at the FBRI VTC Neuromotor Research Clinic. All participation is voluntary and no children will denied services if families choose not to participate.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Laura Bateman
- Phone Number: 540-526-2033
- Email: Laurapb2@vtc.vt.edu
Study Contact Backup
- Name: Stephanie DeLuca, PhD
- Phone Number: 540-526-2098
- Email: stephdeluca@vt.edu
Study Locations
-
-
Virginia
-
Roanoke, Virginia, United States, 24016
- Recruiting
- Fralin Biomedical Research Institute - VTC
-
Contact:
- Laura Bateman
- Phone Number: 540-526-2033
- Email: Laurapb2@vtc.vt.edu
-
Contact:
- Stephanie DeLuca, PhD
- Phone Number: 540-526-2098
- Email: stephdeluca@vt.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Neuromotor Impairment
Exclusion Criteria:
- fragile health
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Children and Adults with Cerebral Palsy
|
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs
|
Children and Adults with Microcephaly
|
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs
|
Children and Adults with other Neuromotor Impairments
|
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs
|
Children who have had a stroke
|
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Emerging Behaviors Scale
Time Frame: up to 12 months
|
This is a measure of the number of skills a child uses from a set of 31 typical used on a daily basis
|
up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assisting Hand Assessment
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
|
This is a measure of bimanual arm and hand use
|
Within 1 week prior to treatment and Within 1 week after treatment
|
Pediatric Motor Activity Log
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
|
This is a parental report about a child's ability to use an impaired arm and hand on a daily basis
|
Within 1 week prior to treatment and Within 1 week after treatment
|
Peabody Developmental Motor Scales 2
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
|
This is a measure of a child's motor abilities in comparison to typical development
|
Within 1 week prior to treatment and Within 1 week after treatment
|
The Bayley Motor Scales of Infant Development -III
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
|
This is a measure of a infants's motor abilities in comparison to typical development
|
Within 1 week prior to treatment and Within 1 week after treatment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Video Assessments
Time Frame: Within 1 week prior to treatment, during treatment, and Within 1 week after treatment
|
Videos of play and therapy sessions
|
Within 1 week prior to treatment, during treatment, and Within 1 week after treatment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stephanie DeLuca, PhD, Virginia Polytechnic Institute and State University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Wounds and Injuries
- Congenital Abnormalities
- Brain Damage, Chronic
- Musculoskeletal Diseases
- Craniocerebral Trauma
- Trauma, Nervous System
- Craniofacial Abnormalities
- Musculoskeletal Abnormalities
- Malformations of Cortical Development, Group I
- Malformations of Cortical Development
- Nervous System Malformations
- Cerebral Palsy
- Brain Injuries
- Brain Injuries, Traumatic
- Microcephaly
Other Study ID Numbers
- 13-196
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
-
Northwestern UniversityActive, not recruitingCerebral Palsy | Diplegic Cerebral Palsy | Bilateral Cerebral PalsyUnited States
-
Centre Médico-Chirurgical de Réadaptation des Massues...RecruitingCerebral Palsy, Dyskinetic | Cerebral Palsy, Spastic | Infantile Hemiplegic Cerebral PalsyFrance
-
St Mary's University CollegeUniversity of GloucestershireUnknownCerebral Palsy | Cerebral Palsy Ataxic | Cerebral Palsy, MixedUnited Kingdom
-
Hilde FeysHasselt University; ETH Zurich; Curtin UniversityRecruitingHemiplegic Cerebral Palsy | Cerebral Palsy, SpasticBelgium
-
University of California, San FranciscoNational Institutes of Health (NIH)RecruitingDystonic Cerebral Palsy | Dyskinetic Cerebral PalsyUnited States
-
MTI UniversityEnrolling by invitationSpastic Diplegic Cerebral PalsyEgypt
-
East Carolina UniversityRecruitingHemiplegic Cerebral Palsy | Unilateral Cerebral Palsy | Remote Ischemic ConditioningUnited States
-
October 6 UniversityCompletedSpastic Cerebral Palsy | Spastic Hemiplegic Cerebral PalsyEgypt
-
Marmara UniversityUnknownCerebral Palsy, Spastic | Cerebral Palsy, Spastic, DiplegicTurkey
Clinical Trials on ACQUIRE Therapy
-
Virginia Polytechnic Institute and State UniversityAmerican Academy for Cerebral Palsy and Developmental MedicineCompletedMicrocephaly | Global Developmental Delay | Hyperkinesis With Developmental DelayUnited States
-
Virginia Polytechnic Institute and State UniversityMedical University of South Carolina; Stanford University; Ohio State University and other collaboratorsRecruitingHemiparesis | Perinatal StrokeUnited States
-
Royal Brompton & Harefield NHS Foundation TrustUnknown
-
AdventHealthCompletedPancreatic NeoplasmUnited States
-
AdventHealthCompletedPancreatic NeoplasmUnited States
-
Société Française d'Endoscopie DigestiveCompletedPancreatic Adenocarcinoma | Pancreas CancerFrance
-
Singapore General HospitalCompletedSolid Tumor | Histological Type of NeoplasmSingapore
-
Société Française d'Endoscopie DigestiveCompletedPancreatic Tumor | PunctureFrance
-
Bristol-Myers SquibbRecruitingPsoriatic ArthritisItaly, United States, Australia, Argentina, Brazil, Czechia, France, Hungary, Mexico, Russian Federation, China, Poland, Finland, Colombia, United Kingdom, Bulgaria, Taiwan, Chile, Romania, Spain, Ireland
-
University of Alabama at BirminghamCompleted